Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alloantiserum recognizing a DQw2 split which is associated with DR3.

B Flesch1, J Neppert, P Ziegler

  • 1Institute of Clinical Immunology and Blood Transfusion, Justus-Liebig-University, Giessen, FRG.

Vox Sanguinis
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel method for the accurate quantification of two isomeric mercapturic acids of 1,3-dichlorobenzene in human urine using isotope dilution online-SPE-LC-MS/MS.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2024
Same author

A straightforward method for determination of the sevoflurane metabolite hexafluoroisopropanol in urinary occupational medical samples by headspace-gas chromatography mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2023
Same author

Correspondence on "Machine Learning-Assisted Identification and Quantification of Hydroxylated Metabolites of Polychlorinated Biphenyls in Animal Samples".

Environmental science & technology·2023
Same author

Excretion kinetics of 1,3-dichlorobenzene and its urinary metabolites after controlled airborne exposure in human volunteers.

Archives of toxicology·2023
Same author

Combining ACL Reconstruction and Refixation: the Single Anteromedial Bundle Biological Augmentation and Refixation (SAMBBAR) Technique.

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca·2022
Same author

Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2022
Same journal

Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework.

Vox sanguinis·2026
Same journal

Haemolytic disease of the foetus and newborn due to anti-M: A systematic review.

Vox sanguinis·2026
Same journal

In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

Vox sanguinis·2026
Same journal

Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

Vox sanguinis·2026
Same journal

Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

Vox sanguinis·2026
Same journal

Abstracts of the 39th International Congress of the ISBT, Kuala Lumpur, Malaysia, 20-24 June 2026.

Vox sanguinis·2026
See all related articles

A novel serum, MUE 38539 II, specifically identifies a subtype of DQw2 associated with DR3. This finding aids in understanding human leukocyte antigen (HLA) variations and their implications in immunology.

Area of Science:

  • Immunogenetics
  • Human Leukocyte Antigen (HLA) complex

Background:

  • The Human Leukocyte Antigen (HLA) complex plays a crucial role in immune response.
  • Specific HLA alleles, such as DR3 and DQw2, are associated with various autoimmune diseases.
  • Accurate typing of HLA antigens is essential for transplantation and disease association studies.

Purpose of the Study:

  • To characterize a newly identified typing serum, MUE 38539 II.
  • To determine the specificity of MUE 38539 II within the HLA system, particularly concerning DR3 and DQw2.
  • To investigate the potential of MUE 38539 II as a tool for identifying specific HLA antigen associations.

Main Methods:

  • Cytotoxicity testing using MUE 38539 II on B lymphocytes and monocytes from DR3-positive donors.
  • Lymphocytotoxicity tests with MUE 38539 II on DR7- and DQw2-positive cells.

Related Experiment Videos

  • Testing reactivity against a DQw4- and DR3-positive lymphoblastoid cell line (RSH).
  • Analysis of HLA antigen linkage in a family with unusual DR3 and DQw2 associations.

    • Main Results:

    • Serum MUE 38539 II demonstrated specific reactivity with B lymphocytes, but not monocytes, of DR3-positive individuals.
    • The serum showed negative results with DR7- and DQw2-positive cells.
    • MUE 38539 II did not react with the RSH cell line, supporting its specificity for a DQw2 split, not DR3.
    • Exclusively cytotoxic reactions were observed with DQw2-positive cells, irrespective of DR3 presence, in family studies.

    Conclusions:

    • Serum MUE 38539 II recognizes a specific subtype of DQw2 antigen, which is associated with DR3.
    • This serum's specificity differs from other DR3 typing reagents.
    • MUE 38539 II provides a valuable tool for dissecting complex HLA associations, particularly involving DQw2 and DR3.